首页 > 最新文献

Journal of Bone and Joint Surgery, American Volume最新文献

英文 中文
Sex-Based Differences in Cell Types and Gene Expression within the Anterior Cruciate Ligament. 前交叉韧带细胞类型和基因表达的性别差异。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-26 DOI: 10.2106/JBJS.25.00860
Steven M Garcia, Justin Lau, Aboubacar Wague, Sankalp Sharma, Kevin C Wang, Miguel Lizarraga, Cristhian Montenegro, Xuhui Liu, Grace O'Connell, Stephanie E Wong, Brian T Feeley

Background: Sex-based disparities remain a major challenge in musculoskeletal medicine. Women and men experience different anterior cruciate ligament (ACL) injury rates and severity, but the causes remain unclear. We hypothesized that cellular differences in human progenitor cells contribute to the higher ACL tear risk observed in females.

Methods: ACL samples were collected from 4 male and 5 female patients undergoing ACL reconstruction surgery. Live cells were collected through flow cytometry and sent for single-cell RNA sequencing. Significantly greater expression in either sex relative to the other was defined as a >25% increase in expression level (log2 fold change > 0.32) and p < 0.05). Subpopulation characterization was performed with immunofluorescence on tissue sections.

Results: We discovered sex-based differences in all of the native cell types within the ACL. In particular, fibroblast progenitor-like (TPPP3+) cells from female patients expressed genes associated with dysregulation and degradation of collagen more highly than progenitor cells from male patients.

Conclusions: These results highlight a ligament progenitor population with a sex-dependent gene expression profile. This work suggests that sex-based differences in stem cell populations may drive differential injury rates and outcomes between male and female patients with musculoskeletal injuries.

Clinical relevance: The differential gene expression among TPPP3+ progenitor-like cells provides a possible target population for studying ligamentous injury and regeneration. Differential expression of collagen and extracellular matrix-related genes provides evidence of specific genes that could be therapeutically targeted to strengthen the ACL and reduce the risk of rupture, particularly in female athletes.

背景:基于性别的差异仍然是肌肉骨骼医学的主要挑战。女性和男性经历不同的前交叉韧带损伤率和严重程度,但原因尚不清楚。我们假设人类祖细胞的细胞差异导致女性ACL撕裂风险较高。方法:对行ACL重建手术的患者进行ACL标本采集,男4例,女5例。流式细胞术采集活细胞,进行单细胞RNA测序。其中任何一种性别相对于另一种性别的表达显著增加,定义为表达水平增加>25% (log2倍变化> 0.32),p < 0.05)。用免疫荧光在组织切片上进行亚群表征。结果:我们发现了ACL内所有原生细胞类型的性别差异。特别是,来自女性患者的成纤维细胞祖细胞样(TPPP3+)细胞比来自男性患者的祖细胞表达的与胶原蛋白失调和降解相关的基因更高。结论:这些结果突出了具有性别依赖性基因表达谱的韧带祖细胞群体。这项研究表明,基于性别的干细胞群差异可能导致男性和女性肌肉骨骼损伤患者的损伤率和结果不同。临床意义:TPPP3+祖样细胞之间的差异基因表达为研究韧带损伤和再生提供了可能的目标群体。胶原蛋白和细胞外基质相关基因的差异表达提供了特异性基因的证据,这些基因可以在治疗上靶向加强前交叉韧带并降低破裂的风险,特别是在女运动员中。
{"title":"Sex-Based Differences in Cell Types and Gene Expression within the Anterior Cruciate Ligament.","authors":"Steven M Garcia, Justin Lau, Aboubacar Wague, Sankalp Sharma, Kevin C Wang, Miguel Lizarraga, Cristhian Montenegro, Xuhui Liu, Grace O'Connell, Stephanie E Wong, Brian T Feeley","doi":"10.2106/JBJS.25.00860","DOIUrl":"https://doi.org/10.2106/JBJS.25.00860","url":null,"abstract":"<p><strong>Background: </strong>Sex-based disparities remain a major challenge in musculoskeletal medicine. Women and men experience different anterior cruciate ligament (ACL) injury rates and severity, but the causes remain unclear. We hypothesized that cellular differences in human progenitor cells contribute to the higher ACL tear risk observed in females.</p><p><strong>Methods: </strong>ACL samples were collected from 4 male and 5 female patients undergoing ACL reconstruction surgery. Live cells were collected through flow cytometry and sent for single-cell RNA sequencing. Significantly greater expression in either sex relative to the other was defined as a >25% increase in expression level (log2 fold change > 0.32) and p < 0.05). Subpopulation characterization was performed with immunofluorescence on tissue sections.</p><p><strong>Results: </strong>We discovered sex-based differences in all of the native cell types within the ACL. In particular, fibroblast progenitor-like (TPPP3+) cells from female patients expressed genes associated with dysregulation and degradation of collagen more highly than progenitor cells from male patients.</p><p><strong>Conclusions: </strong>These results highlight a ligament progenitor population with a sex-dependent gene expression profile. This work suggests that sex-based differences in stem cell populations may drive differential injury rates and outcomes between male and female patients with musculoskeletal injuries.</p><p><strong>Clinical relevance: </strong>The differential gene expression among TPPP3+ progenitor-like cells provides a possible target population for studying ligamentous injury and regeneration. Differential expression of collagen and extracellular matrix-related genes provides evidence of specific genes that could be therapeutically targeted to strengthen the ACL and reduce the risk of rupture, particularly in female athletes.</p>","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146052355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cost-Effectiveness of Enoxaparin Compared with Aspirin for Thromboprophylaxis in Patients with Orthopaedic Trauma. 依诺肝素与阿司匹林在骨科创伤患者血栓预防中的成本-效果比较。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-26 DOI: 10.2106/JBJS.25.00681
Joseph F Levy, Robert V O'Toole, Deborah M Stein, Elliott R Haut, Katherine P Frey, Renan C Castillo, Nathan N O'Hara

Background: Although clinical guidelines endorse enoxaparin for the prevention of venous thromboembolism in patients with orthopaedic trauma, recent evidence from a large clinical trial has demonstrated that aspirin provides comparable protection against death and pulmonary embolism. This study evaluated the cost-effectiveness of thromboprophylaxis with enoxaparin compared with that with aspirin in patients with orthopaedic trauma from the perspective of the U.S. health-care system.

Methods: The study modeled a hypothetical cohort of adult patients with an operatively treated extremity, pelvic, or acetabular fracture based on data from a recent clinical trial and national databases. We used a decision analysis model to compare 30 mg of enoxaparin with 81 mg of aspirin, administered twice daily in-hospital and prescribed for 21 days after discharge. Health-care costs and quality-adjusted life-years (QALYs) within 1 year after the injury derived from published research and publicly available cost data were based on potential disease states, including death or a combination of pulmonary embolism, proximal deep vein thrombosis, distal deep vein thrombosis, or a bleeding complication. We assessed cost-effectiveness compared with a willingness-to-pay threshold of $150,000 per QALY.

Results: Our model estimated that the 1-year health-care costs among patients prescribed enoxaparin were $35,301, producing 0.6705 QALYs. Aspirin was associated with $35,067 in 1-year health-care costs and 0.6701 QALYs. The overall health-care costs were $234 higher with enoxaparin but yielded only a 0.0004 improvement in QALYs, for an incremental cost-effectiveness ratio for enoxaparin of $635,340 per QALY, indicating that enoxaparin is not cost-effective compared with aspirin. In a sensitivity analysis, the probability of enoxaparin thromboprophylaxis being cost-effective compared with aspirin was 9.8% in 10,000 iterations.

Conclusions: The findings suggest that enoxaparin is not cost-effective relative to aspirin for thromboprophylaxis in patients with orthopaedic trauma. The results support consideration of aspirin as a preferred agent in future guidelines, especially given the consistent patient preference for its oral administration.

Level of evidence: Economic and Decision Analysis Level I. See Instructions for Authors for a complete description of levels of evidence.

背景:尽管临床指南支持依诺肝素预防骨科创伤患者的静脉血栓栓塞,但最近一项大型临床试验的证据表明,阿司匹林对死亡和肺栓塞的保护作用相当。本研究从美国医疗保健系统的角度评估了依诺肝素与阿司匹林在骨科创伤患者中预防血栓的成本-效果。方法:该研究基于最近的临床试验和国家数据库的数据,模拟了一组手术治疗的四肢、骨盆或髋臼骨折的成人患者。我们使用决策分析模型比较了30毫克依诺肝素和81毫克阿司匹林,每日两次,出院后21天开处方。医疗保健费用和损伤后1年内的质量调整生命年(QALYs)来自已发表的研究和公开可获得的成本数据,基于潜在的疾病状态,包括死亡或肺栓塞、近端深静脉血栓形成、远端深静脉血栓形成或出血并发症的组合。我们将成本效益与每个QALY的支付意愿阈值15万美元进行了比较。结果:我们的模型估计,依诺肝素处方患者的1年医疗保健成本为35,301美元,产生0.6705个qaly。阿司匹林与1年医疗保健费用35,067美元和质量年0.6701相关。使用依诺肝素的总体医疗保健费用增加了234美元,但质量aly仅改善了0.0004,因为依诺肝素的增量成本效益比为每个质量aly 635 340美元,这表明与阿司匹林相比,依诺肝素的成本效益不高。在敏感性分析中,与阿司匹林相比,依诺肝素预防血栓的成本效益概率在10,000次迭代中为9.8%。结论:研究结果表明,在骨科创伤患者的血栓预防中,依诺肝素与阿司匹林相比没有成本效益。结果支持在未来的指南中考虑阿司匹林作为首选药物,特别是考虑到患者对口服阿司匹林的一贯偏好。证据等级:经济和决策分析i级。参见《作者说明》获得证据等级的完整描述。
{"title":"The Cost-Effectiveness of Enoxaparin Compared with Aspirin for Thromboprophylaxis in Patients with Orthopaedic Trauma.","authors":"Joseph F Levy, Robert V O'Toole, Deborah M Stein, Elliott R Haut, Katherine P Frey, Renan C Castillo, Nathan N O'Hara","doi":"10.2106/JBJS.25.00681","DOIUrl":"https://doi.org/10.2106/JBJS.25.00681","url":null,"abstract":"<p><strong>Background: </strong>Although clinical guidelines endorse enoxaparin for the prevention of venous thromboembolism in patients with orthopaedic trauma, recent evidence from a large clinical trial has demonstrated that aspirin provides comparable protection against death and pulmonary embolism. This study evaluated the cost-effectiveness of thromboprophylaxis with enoxaparin compared with that with aspirin in patients with orthopaedic trauma from the perspective of the U.S. health-care system.</p><p><strong>Methods: </strong>The study modeled a hypothetical cohort of adult patients with an operatively treated extremity, pelvic, or acetabular fracture based on data from a recent clinical trial and national databases. We used a decision analysis model to compare 30 mg of enoxaparin with 81 mg of aspirin, administered twice daily in-hospital and prescribed for 21 days after discharge. Health-care costs and quality-adjusted life-years (QALYs) within 1 year after the injury derived from published research and publicly available cost data were based on potential disease states, including death or a combination of pulmonary embolism, proximal deep vein thrombosis, distal deep vein thrombosis, or a bleeding complication. We assessed cost-effectiveness compared with a willingness-to-pay threshold of $150,000 per QALY.</p><p><strong>Results: </strong>Our model estimated that the 1-year health-care costs among patients prescribed enoxaparin were $35,301, producing 0.6705 QALYs. Aspirin was associated with $35,067 in 1-year health-care costs and 0.6701 QALYs. The overall health-care costs were $234 higher with enoxaparin but yielded only a 0.0004 improvement in QALYs, for an incremental cost-effectiveness ratio for enoxaparin of $635,340 per QALY, indicating that enoxaparin is not cost-effective compared with aspirin. In a sensitivity analysis, the probability of enoxaparin thromboprophylaxis being cost-effective compared with aspirin was 9.8% in 10,000 iterations.</p><p><strong>Conclusions: </strong>The findings suggest that enoxaparin is not cost-effective relative to aspirin for thromboprophylaxis in patients with orthopaedic trauma. The results support consideration of aspirin as a preferred agent in future guidelines, especially given the consistent patient preference for its oral administration.</p><p><strong>Level of evidence: </strong>Economic and Decision Analysis Level I. See Instructions for Authors for a complete description of levels of evidence.</p>","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146052351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Orthopaedics Education: Doing More with Less. 全球骨科教育:少花钱多办事。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-24 DOI: 10.2106/JBJS.25.00443
Laura Robbins, Mathias Bostrom, Adolfo Llinás
{"title":"Global Orthopaedics Education: Doing More with Less.","authors":"Laura Robbins, Mathias Bostrom, Adolfo Llinás","doi":"10.2106/JBJS.25.00443","DOIUrl":"10.2106/JBJS.25.00443","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":"100-102"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12794706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's New in Adult Reconstructive Knee Surgery. 成人膝关节重建手术的新进展。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-12-01 DOI: 10.2106/JBJS.25.01212
T David Luo, Sebastian B Braun, Brent A Lanting
{"title":"What's New in Adult Reconstructive Knee Surgery.","authors":"T David Luo, Sebastian B Braun, Brent A Lanting","doi":"10.2106/JBJS.25.01212","DOIUrl":"https://doi.org/10.2106/JBJS.25.01212","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":"108 2","pages":"83-91"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disconfirmation Bias May Exist in All of Us, But Being Aware Is the First Step Toward Critical Thinking. 不确定的偏见可能存在于我们所有人身上,但意识到这一点是走向批判性思维的第一步。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-13 DOI: 10.2106/JBJS.25.00494
Dipit Sahu
{"title":"Disconfirmation Bias May Exist in All of Us, But Being Aware Is the First Step Toward Critical Thinking.","authors":"Dipit Sahu","doi":"10.2106/JBJS.25.00494","DOIUrl":"10.2106/JBJS.25.00494","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":"98-99"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pause, and Appreciate. 暂停一下,欣赏一下。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-13 DOI: 10.2106/JBJS.25.00364
Benjamin A Nelson
{"title":"Pause, and Appreciate.","authors":"Benjamin A Nelson","doi":"10.2106/JBJS.25.00364","DOIUrl":"10.2106/JBJS.25.00364","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":"103"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence, Characteristics, and Management of Concomitant Ipsilateral Upper-Extremity Fractures in Pediatric Monteggia Fracture-Dislocations: A 13-Year Single-Institution Case Series. 儿童蒙氏骨折脱位并发同侧上肢骨折的发生率、特点和处理:一项13年单机构病例系列研究。
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-24 DOI: 10.2106/JBJS.25.00474
Jason Zarahi Amaral, Jay Moran, Rioke M Diejomaoh, Stuart D Ferrell, Basel M Touban, Jessica A McGraw-Heinrich, Scott D McKay
<p><strong>Background: </strong>Monteggia fracture-dislocations are uncommon pediatric injuries that often require surgical stabilization. Concomitant ipsilateral upper-extremity fractures are rare, are poorly characterized, and may be missed during initial evaluation. In this study, we aimed to evaluate the incidence, characteristics, and management of acute pediatric Monteggia fracture-dislocations with concomitant ipsilateral upper-extremity fractures.</p><p><strong>Methods: </strong>A retrospective review was conducted at a single tertiary academic center from 2011 to 2024. Patients ≤18 years of age with acute Monteggia or Monteggia-equivalent fracture-dislocations were identified and categorized using the Bado classification. Patients with concomitant ipsilateral upper-extremity fractures were identified and reported descriptively. The rates of formal operative reduction and ulnar fracture fixation were compared between patients with and without concomitant fractures.</p><p><strong>Results: </strong>In total, 468 pediatric patients with Monteggia fracture-dislocations (mean age, 6.3 ± 2.5 years; 49% female; 48% White, 39% Hispanic, 8% Asian, 3% Black, and 2% not specified) were included. Of these, 32 (7%) had ≥1 concomitant ipsilateral upper-extremity fracture. Bado I was most common among patients with concomitant fractures (59%). Concomitant fracture types included distal radial fractures in 59%, supracondylar humeral fractures in 34%, distal ulnar fractures in 25%, medial epicondylar fractures of the humerus in 9%, and lateral condylar fractures of the humerus in 6%. The observed fracture combinations, in decreasing order, were Monteggia fracture-dislocation with distal radial fracture (34%), with supracondylar humeral fracture (25%), and with combined distal radial and distal ulnar fractures (16%). Additional patterns included Monteggia fracture-dislocation with combined supracondylar humeral, distal radial, and distal ulnar fractures (9%); with medial epicondylar fracture of the humerus (9%); and with lateral condylar fracture of the humerus (6%). Patients with concomitant fractures more frequently underwent formal operative reduction (78% versus 48%; p = 0.001) and ulnar fracture fixation (66% versus 37%; p = 0.001) compared with those with isolated Monteggia fracture-dislocations.</p><p><strong>Conclusions: </strong>Concomitant ipsilateral upper-extremity fractures were identified in 7% of acute pediatric Monteggia fracture-dislocations, most frequently involving the distal radius (59%) and the supracondylar region of the humerus (34%). Patients with concomitant fractures more commonly underwent formal operative reduction and ulnar fracture fixation compared with those without concomitant fractures. Given the 7% incidence, surgeons should maintain a high index of suspicion for subtle secondary injuries and ensure appropriate imaging during initial evaluation. Further research is needed to guide management and rehabilitation in these c
背景:蒙特吉亚骨折脱位是一种罕见的儿童损伤,通常需要手术稳定。伴随的同侧上肢骨折是罕见的,特征不明确,并且可能在初始评估时被遗漏。在本研究中,我们旨在评估急性小儿蒙氏骨折脱位合并同侧上肢骨折的发生率、特点和处理。方法:对2011年至2024年在某高等院校开展的研究进行回顾性分析。≤18岁的急性Monteggia或相当于Monteggia的骨折脱位患者被识别并使用Bado分类。对伴有同侧上肢骨折的患者进行了鉴定和描述性报道。比较合并和不合并骨折患者的正式手术复位率和尺骨骨折固定率。结果:共纳入468例蒙氏骨折脱位患儿(平均年龄6.3±2.5岁,女性49%,白人48%,西班牙裔39%,亚裔8%,黑人3%,2%未明确)。其中32例(7%)伴有≥1例同侧上肢骨折。伴有骨折的患者中最常见的是Bado I型(59%)。伴随骨折类型包括桡骨远端骨折占59%,肱骨髁上骨折占34%,尺骨远端骨折占25%,肱骨上髁内侧骨折占9%,肱骨外侧髁骨折占6%。观察到的骨折组合由大到小依次为Monteggia骨折脱位合并桡骨远端骨折(34%)、肱骨髁上骨折(25%)、桡骨远端和尺侧远端合并骨折(16%)。其他类型包括Monteggia骨折脱位合并肱骨髁上、桡骨远端和尺骨远端骨折(9%);肱骨内上髁骨折(9%);肱骨外侧髁骨折(6%)。与孤立性Monteggia骨折脱位患者相比,合并骨折患者更常接受正式手术复位(78%对48%,p = 0.001)和尺骨骨折固定(66%对37%,p = 0.001)。结论:7%的儿童急性Monteggia骨折脱位并发上肢骨折,最常见的是桡骨远端(59%)和肱骨髁上区(34%)。与没有合并骨折的患者相比,合并骨折的患者更常接受正式的手术复位和尺骨骨折固定。鉴于7%的发生率,外科医生应对细微的继发性损伤保持高度怀疑,并确保在初步评估时进行适当的影像学检查。需要进一步的研究来指导这些复杂病例的管理和康复。证据等级:治疗性IV级。参见《作者说明》获得证据等级的完整描述。
{"title":"Incidence, Characteristics, and Management of Concomitant Ipsilateral Upper-Extremity Fractures in Pediatric Monteggia Fracture-Dislocations: A 13-Year Single-Institution Case Series.","authors":"Jason Zarahi Amaral, Jay Moran, Rioke M Diejomaoh, Stuart D Ferrell, Basel M Touban, Jessica A McGraw-Heinrich, Scott D McKay","doi":"10.2106/JBJS.25.00474","DOIUrl":"10.2106/JBJS.25.00474","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Monteggia fracture-dislocations are uncommon pediatric injuries that often require surgical stabilization. Concomitant ipsilateral upper-extremity fractures are rare, are poorly characterized, and may be missed during initial evaluation. In this study, we aimed to evaluate the incidence, characteristics, and management of acute pediatric Monteggia fracture-dislocations with concomitant ipsilateral upper-extremity fractures.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective review was conducted at a single tertiary academic center from 2011 to 2024. Patients ≤18 years of age with acute Monteggia or Monteggia-equivalent fracture-dislocations were identified and categorized using the Bado classification. Patients with concomitant ipsilateral upper-extremity fractures were identified and reported descriptively. The rates of formal operative reduction and ulnar fracture fixation were compared between patients with and without concomitant fractures.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In total, 468 pediatric patients with Monteggia fracture-dislocations (mean age, 6.3 ± 2.5 years; 49% female; 48% White, 39% Hispanic, 8% Asian, 3% Black, and 2% not specified) were included. Of these, 32 (7%) had ≥1 concomitant ipsilateral upper-extremity fracture. Bado I was most common among patients with concomitant fractures (59%). Concomitant fracture types included distal radial fractures in 59%, supracondylar humeral fractures in 34%, distal ulnar fractures in 25%, medial epicondylar fractures of the humerus in 9%, and lateral condylar fractures of the humerus in 6%. The observed fracture combinations, in decreasing order, were Monteggia fracture-dislocation with distal radial fracture (34%), with supracondylar humeral fracture (25%), and with combined distal radial and distal ulnar fractures (16%). Additional patterns included Monteggia fracture-dislocation with combined supracondylar humeral, distal radial, and distal ulnar fractures (9%); with medial epicondylar fracture of the humerus (9%); and with lateral condylar fracture of the humerus (6%). Patients with concomitant fractures more frequently underwent formal operative reduction (78% versus 48%; p = 0.001) and ulnar fracture fixation (66% versus 37%; p = 0.001) compared with those with isolated Monteggia fracture-dislocations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Concomitant ipsilateral upper-extremity fractures were identified in 7% of acute pediatric Monteggia fracture-dislocations, most frequently involving the distal radius (59%) and the supracondylar region of the humerus (34%). Patients with concomitant fractures more commonly underwent formal operative reduction and ulnar fracture fixation compared with those without concomitant fractures. Given the 7% incidence, surgeons should maintain a high index of suspicion for subtle secondary injuries and ensure appropriate imaging during initial evaluation. Further research is needed to guide management and rehabilitation in these c","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":"134-141"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Through Their Eyes: Doctors or Monsters? 透过他们的眼睛:医生还是怪物?
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-17 DOI: 10.2106/JBJS.25.00263
Carol Zhao Xiaoshu
{"title":"Through Their Eyes: Doctors or Monsters?","authors":"Carol Zhao Xiaoshu","doi":"10.2106/JBJS.25.00263","DOIUrl":"https://doi.org/10.2106/JBJS.25.00263","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":"108 2","pages":"104-106"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Am I That Guy? 我是那个人吗?
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-21 Epub Date: 2025-11-20 DOI: 10.2106/JBJS.25.00506
Joseph Bernstein
{"title":"Am I That Guy?","authors":"Joseph Bernstein","doi":"10.2106/JBJS.25.00506","DOIUrl":"10.2106/JBJS.25.00506","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":"96-97"},"PeriodicalIF":4.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Podagra.
IF 4.3 1区 医学 Q1 ORTHOPEDICS Pub Date : 2026-01-13 DOI: 10.2106/JBJS.25.01513
Kiana C Allen
{"title":"Podagra.","authors":"Kiana C Allen","doi":"10.2106/JBJS.25.01513","DOIUrl":"https://doi.org/10.2106/JBJS.25.01513","url":null,"abstract":"","PeriodicalId":15273,"journal":{"name":"Journal of Bone and Joint Surgery, American Volume","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Bone and Joint Surgery, American Volume
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1